Professional Documents
Culture Documents
Prevention
Jean R. Anderson, MD Director Johns Hopkins HIV Womens Health Program
Resources
A Guide to the Clinical Care of Women With HIV: 2001 First Edition
To request the guide, send e-mail to ask@hrsa.gov
Learning Objectives
Why prevention is important Progress made in HIV prevention Modes of HIV transmission Most effective interventions for reducing transmission
Performance Objectives
Explain why prevention is important Demonstrate progress made in HIV prevention Discuss the modes of HIV transmission Describe the most effective interventions for reducing transmission
Risk Perception: Percentage of Sexually Active Women (1519) Who Think They Are not at Risk of Getting AIDS
Guatemala Brazil Niger Chad Mali Togo Haiti Kenya Uganda Zambia Zimbabwe
0 20 87% 52% 87% 60%
21%
52% 50% 40 60 Percentage 80 100
Risk Perception: Percentage of Sexually Active Women (1519) Who Think They Are not at Risk of Getting AIDS
Guatemala 1% Brazil 1% 52% 1% Niger Chad 2% 60% 3% Mali 46% 7% Togo 45% 10% Haiti 63% 16% Kenya 36% 19%21% Uganda 27% Zambia 52% 30% Zimbabwe 50%
0 20 40 60 Percentage 80 87% 87% HIV prevalence rate in women attending antenatal care clinics in major urban areas (at time of survey) 100
Thailand, 21 year old military conscripts2 Dakar, Senegal, all ages antenatal clients1
20
15
10
0
1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999
Source: 1National STD/AIDS Control Programmes; 2Armed Forces Research Institute of Medical Sciences
Percentage Sexually Experienced by Current Age (1524 years old) in 1989 and 1995 Uganda
100
% Sexually Experienced
75
50
25
0 15 16 17 18 19 20 Age 21 22 23 24
Substantial and Sustained Risk Reduction in Urban Males Visiting Sex Workers 19901997 Thailand
50 45 40 35 30 25 20 15 10 5 0 Age 20-24 Age 25-29
Modes of Transmission
Sexual most common mode of transmission globally Risk per episode
Receptive vaginal intercourse: 0.10.2% Receptive anal intercourse: 0.13% Insertive vaginal intercourse: 0.1% Insertive anal intercourse: 0.06% Receptive oral intercourse: 0.04%
10
N/A
N/A ?
? ? ?
11
Modes of Transmission
continued
Parenteral
Transfusion: 95% risk of infection with single unit of whole blood Injection drug use: 0.67% risk per exposure Healthcare workers (needlestick): 0.4% risk per exposure
12
Modes of Transmission
continued
Perinatal
2530% risk of transmission without antiretroviral therapy or scheduled cesarean section
Traditional practices
Circumcision, ear piercing, tattooing, ritual scarification with shared and non-sterile or nondisinfected instruments
13
Modes of Transmission
continued
Behavioral interventions to reduce risk behavior Condoms (dual protection or dual use) Sexually transmitted infection (STI) prevention and treatment
15
Antitretroviral (ARV) and breastfeeding interventions to prevent mother-to-child transmission (MTCT) Safe transfusion practices
16
HIV prevention counseling is effective at reducing risky behaviors in HIV-infected and 17 uninfected persons
Behavioral Interventions
Education Recognition of risks Recognition of barriers to risk reduction Motivation to change Risk reduction plan
18
Risk Assessment
Age < 25 yrs Single Sexual behavior: woman or partner
More than one partner in last 3 months Multiple partners New or casual partner
Mobile population
Refugee Husband in military or long-distance truck driver
History of substance abuse Pregnant History of tuberculosis (TB) Sex worker Signs or symptoms 19 suggesting HIV
20
Condoms
Most effective method to prevent HIV transmission and STI acquisition Male and female condoms available Clients should be instructed in proper use Consistent use must be emphasized
Male Condom
Female Condom
21
Percentage of Sexually Active Men and Women Who Have Ever Used a Condom, Urban Uganda, 1989 and 1995
70
% Ever-Used Condoms
Dual Protection
Dual protection: Protection against pregnancy, HIV and other STDs Achieved by:
Avoidance of penetrative sex Mutual monogamy between non-infected partners using effective contraception Condom use alone Dual method: Condom use in combination with other contraceptives
23
24
Female Condom
Made from polyurethane
Can be inserted prior to intercourse - does not require erect penis Does not need to be removed immediately after ejaculation Can be safely reused if washed, rinsed and air dried after initial use 25
27
IUD
No STI or HIV protection Increased menstrual flow and duration with nonprogesterone containing IUDs may increase transmission risk and risk of anemia No increase in cervical HIV shedding four months after insertion.
28
Source: Richardson 1999.
Voluntary sterilization
No STI or HIV protection Decreased risk of PID
29
Condoms Sexual behavior change Recognition of risk factors and early symptoms Syndromic management
Genital ulcer disease Urethral discharge in men Vaginal discharge limitations
30
Antenatal screening for syphilis Linkage to programs treating symptomatic men Target high-risk individuals
Sex workers and clients Drug users Military personnel Truck drivers
31
25 20 15 10 5 0
7.5 4.4
Comparison of Increase in Condom Use with Decline in Reported Male STIs on a National Scale, Thailand, 19891994
200 65 Male STDS Condom Non-use
180 160 140 120 100 80 60 40 20 0 1989 1990 1991 1992 1993 1994
45 35 25 15 5 -5
55
35
No Breastfeeding
Thailand Breastfeeding Cte dIvoire 37% (3 months) 38% (6 months) 52% (6 weeks) 38% (6 weeks) 47% (4 months)
36
50%
HIV-positive women
Avoid if safe and affordable alternatives available Teach proper attachment of newborn to nipples and frequent breast emptying Seek prompt treatment of mastitis or breast abscess and oral thrush in newborns Breastfeed exclusively for up to 6 months
37
Prevention TransfusionRelated
Prevent or treat causes of anemia and blood loss
Malnutrition Malaria Parasitic infestation Pregnancy (repeated pregnancies at short intervals, postpartum hemorrhage)
Minimize unnecessary transfusions: Use blood substitutes (crystalloid /colloid) for volume replacement when possible
38
39
40
41
42
Barriers
Complex regimens Resistance issues Side effects and toxicity Cost
43
44
References
1.
2. 3.
4.
5. 6.
Anderson J. HIV and reproduction. In Anderson J (ed): A Guide to the Clinical Care of Women with HIV. HRSA/DHHS, 2001. Armed Forces Research Institute of Medical Sciences. Thailand. Chamratrithirong et al. Review of the 100% Condom Programme, Mahidol University. 2001. Compendium of HIV prevention interventions with evidence of effectiveness. Centers for Disease Control and Prevention, National Center for HIV, STD, and TB Prevention, Division of HIV/AIDS Prevention, Atlanta, Georgia. November 1999. Consultation on STD interventions for preventing HIV: What is the evidence? UNAIDS. May 2000. Female condom-guide for planning and programming. UNAIDS. August 2000.
45
References continued
7. HIV prevention needs and successes: a tale of three countries. UNAIDS. May 2001. 8. HIV prevention strategic plan through 2005. Centers for Disease Control and Prevention. January 2001. Institute of Medicine. No time to lose: getting more from HIV prevention. September, 2000 9. Male condom technical update. UNAIDS. September 2000. National STD/AIDS Control Programmes. Senegal and Uganda. 10. Richardson BA, Morrison CS, Sekadde-Kigondu C, et al. Effect of intrauterine device use on cervical shedding of HIV-1 DNA. AIDS 13:2091-7, 1999. 11. Royce RA, Sena A, Cates W Jr, and Cohen MS. Sexual transmission of HIV. N Engl J Med 336:1072-8, 1997. 12. Sex and youth: Contextual factors affecting risk for HIV/AIDS. UNAIDS. May 1999.
46
References continued
13. Sittitrai W, Phanuphak P, Barry J, et al. A survey of Thai sexual behaviour and risk of HIV infection. Int J STD AIDS (England), SepOct 1994, 5(5) p377-8. 14. Sweat M, Gregorich S, Sangiwa G, et al. Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania. Lancet 2000;356:113-121. 15. Thongthai et al. Media Effectiveness Survey. Mahidol University. 2001 16. UNICEF, DHS surveys, 1994-1999. 17. The voluntary HIV-1 Counseling and Testing Efficacy Study Group. Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: a randomized trial. Lancet 2000;356:103-112. 18. Wang C and Celum C. Prevention of HIV. In Anderson JR (ed): A Guide to the Clinical Care of Women with HIV. DHHS, HRSA, HAB. 47 Washington, D.C. 2001.